↓ Skip to main content

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?

Overview of attention for article published in Frontiers in Pharmacology, June 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
Published in
Frontiers in Pharmacology, June 2018
DOI 10.3389/fphar.2018.00637
Pubmed ID
Authors

Pan Pantziarka, Gauthier Bouche, Nicolas André

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 16%
Student > Doctoral Student 3 10%
Student > Postgraduate 3 10%
Researcher 3 10%
Student > Ph. D. Student 2 6%
Other 5 16%
Unknown 10 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 19%
Medicine and Dentistry 6 19%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Agricultural and Biological Sciences 2 6%
Chemistry 2 6%
Other 3 10%
Unknown 10 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2021.
All research outputs
#6,898,609
of 24,512,028 outputs
Outputs from Frontiers in Pharmacology
#2,982
of 18,532 outputs
Outputs of similar age
#113,159
of 333,304 outputs
Outputs of similar age from Frontiers in Pharmacology
#69
of 389 outputs
Altmetric has tracked 24,512,028 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 18,532 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,304 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 389 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.